Stock Market Today (23 October 2026): BPCL ₹4,900 Cr Plan, Shriram Finance Profit Jumps 59%

Indian stocks remained focused on quarterly earnings and major corporate plans on 23 October 2026. BPCL announced a ₹4,900 crore project in Andhra Pradesh, Shriram Finance delivered a sharp 59% jump in quarterly profit, while Infosys came under pressure after its ADR fell 8% on weak Q2 numbers. Dr. Reddy's Laboratories also reported a significant decline in profit, creating a mixed picture across the IT and pharmaceutical sectors.

Today's Key Market Highlights

BPCL Gets ₹4,900 Crore Capital Approval for Andhra Pradesh Project

Bharat Petroleum Corporation emerged as one of the biggest corporate stories of the day after announcing plans for a ₹4,900 crore greenfield refinery and petrochemical complex at Ramayapatnam in Andhra Pradesh.

BPCL's subsidiary has received approval for an authorised share capital of up to ₹49 billion to support the project and establish a dedicated legal and governance structure for its activities.

Shriram Finance Q2 Profit Jumps 59%

Shriram Finance reported a strong second-quarter performance, with profit rising 59% year on year. The sharp increase places the non-banking finance company among the stronger earnings performers in today's corporate updates.

The result will keep attention on the company's lending growth, asset quality, margins and collection trends as investors assess whether the earnings momentum can continue through the second half of the financial year.

Infosys ADR Falls 8% After Weak Q2

Infosys came under pressure in overseas trading after its American Depositary Receipt fell around 8% following a weak second-quarter performance.

The move is important for domestic investors because the ADR reaction can influence sentiment toward Infosys and the broader Indian IT sector when the Indian market reopens.

Investors will focus on the company's demand environment, deal momentum, margins and management commentary to determine whether the weakness reflects company-specific concerns or a broader slowdown in technology spending.

Unicommerce Reports 11% PAT Growth

Unicommerce eSolutions reported a positive quarterly update, with Q2 profit after tax rising 11% to ₹6.4 crore. Revenue increased 14% during the quarter.

The combination of double-digit revenue and profit growth keeps the company in focus among India's digital commerce and software-enabled business platforms. Investors will watch whether the company can maintain this growth trajectory as the e-commerce ecosystem expands.

Dr. Reddy's Q2 Profit Drops 36%

Dr. Reddy's Laboratories reported a challenging quarter, with Q2 profit declining 36%. The sharp fall makes the pharmaceutical major one of the key earnings disappointments in today's updates.

Investors will be watching the company's product mix, pricing environment, operating costs and upcoming launches to understand whether the decline is temporary or points to a more sustained earnings pressure.

Torrent Pharma Targets 33.5% Plus Margin

Torrent Pharmaceuticals is targeting an EBITDA margin of more than 33.5%, keeping profitability and operating efficiency firmly in focus.

The margin target provides investors with an important benchmark for tracking the company's earnings quality and cost discipline as the business moves through the remainder of the year.

Geojit Financial Reports Lower Profit

Geojit Financial Services reported a decline in quarterly profitability, with separate updates pointing to a year-on-year profit fall in the range of roughly 26% to 31%.

The weaker performance makes trading activity, fee income and market conditions important factors to watch for the financial-services company.

CRISIL Declares ₹17 Per Share Dividend

CRISIL announced a ₹17 per share dividend, providing a direct shareholder-return trigger for the company.

Dividend announcements remain relevant for investors tracking cash-generating businesses and companies with consistent capital-return policies.

JK Tyre Plans Dubai Unit

JK Tyre & Industries is planning to establish a unit in Dubai. The move adds to the company's international expansion efforts and could strengthen its presence in overseas markets.

Investors will watch the scale of the proposed operation and how the new unit fits into JK Tyre's broader international business strategy.

Other Important Corporate Updates

• SBI Card: ICRA reaffirmed the company's AAA rating, supporting its strong credit profile.
• BPCL: Reported no secured debentures while moving ahead with the proposed Andhra Pradesh project structure.
• Unicommerce: Board approved the Q2 and H1 financial results.
• Dr. Reddy's Laboratories: Q2 profit declined 36%, putting the stock under earnings-related scrutiny.
• Geojit Financial Services: Reported a significant year-on-year decline in Q2 profit.

Market Outlook

The latest earnings updates paint a distinctly mixed picture. BPCL's ₹4,900 crore project provides a long-term capital expenditure trigger, while Shriram Finance's 59% profit growth points to strong earnings momentum in the financial-services space.

At the other end of the spectrum, weak results at Infosys and Dr. Reddy's highlight the importance of company-specific earnings quality during the current results season. The sharp fall in Infosys' ADR could also influence sentiment toward IT stocks in the next domestic trading session.

Unicommerce's double-digit growth and Torrent Pharma's margin ambition offer more constructive signals, while CRISIL's dividend and SBI Card's reaffirmed AAA rating provide additional shareholder-return and credit-quality cues.

For the broader market, earnings announcements are likely to remain the primary driver in the near term. Investors should focus on management commentary and forward guidance rather than reacting only to headline profit numbers.

Stocks to Watch